Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Aug 12, 2023 12:19pm
507 Views
Post# 35585345

General comments, leading to Monday am N.R. Etc

General comments, leading to Monday am N.R. Etc

First a shout out to those who know me on a more personal level.
The fireside chat, as I said was cryptic at best.
That I find very interesting. Not discouraging.....I'll explain at the end.
Question , why?
Consider the background of the talk.
The 2 being interviewed. Extremely educated. Dr. Matt , mutiple peer reviewed publications.
My point, they go into these things knowing exactly what to expect & how to interpret.
The questions were pre- arranged. 
Only a fool would be caught off guard with a random " out there" question.
It's called preparation. Again, in their background & training. They are not capable of getting on a mic, without knowing beginning & ending of where things are going to go.
So, why the vague answers & muddy explanations around MBc & panc phase 3 " partners"?
1. If things were dead, or leaning that way...they would not have agreed to the fireside chat.
2. The most positive point they raised, was that the recent $15million was brought in by a single medical affiliation.  " most of it"
3. Matt also said, that was the first time in their history that type of buy , has happened.
Again imho, intersting why a Canadian investor would become close to but just under a 10% holder of the Canadian float.
Back to why encouraging, not discouraging. 

They did say, as they have for many months now. When asked about B.D. Plans.
" we continue to engage with the likes of Pfizer , Roche & others" ..paraphrase, something like that.
Straight up! 

When people give you inconclusive information, they are intentionally not revealing something.
Why would an investor take on a $10-$15 usd , investment in something failing? 
They would not!
Matt et. al. Know exactly who bought those shares & why.
I'm beyond seeing a linear path. 
No doubt lots going on.
Regarding S.P. 

I saw some numbers published, substantially higher shorting the last 30 days.
Monday, hopefully shines some light on the questions. The retail segment hates unknowns & doubt.
Last point.
99.9% of the time, I do not get into direct naming of others who post.
This site in particular has a reasonable exchange of ideas & thoughts about oncolytics biotec, the virus Pelareorep & the progress of many trials. Up to & including rationals of various B.D. Deals.
That is the point if these chat rooms. Additionally, I always refer anyone with doubts to go to company site & read presentations.
or , go back & listen to recordings of interviews.
We do have one very persistent troll. Who BTW is using a stolen name. Buck Henry was the creator of 1960s Get Smart. Long dead.
A quick search of his posts , show time & time again: personal attacks, open negative comments, with zero substance. 
Reminds me of high school washroom wall writings.
The technical word is Ad Hominem attacks.
Just like my curiosity after the recent fireside chat. Why would anyone do that?
motive?
Like I said, lots of shorting lately.
Regardless. My advice for those who can, tune in in Monday.
 

 

<< Previous
Bullboard Posts
Next >>